Omega‑3 testing is now part of routine antenatal screening in South Australia
Omega-3 testing identifies low omega-3 levels early in pregnancy so women can receive targeted supplementation to reduce the risk of preterm birth.
Omega-3 testing in pregnancy - from research to routine care
Omega-3 testing in pregnancy is based on decades of world leading research led by the South Australian Health and Medical Research Institute (SAHMRI).
This research aims to reduce the risk of preterm birth, particularly early preterm birth (babies born before 34 weeks’ gestation), which is one of the leading causes of serious illness and death in newborn babies in developed countries.
Our work has now been translated into a sustainable preterm birth prevention initiative, delivered in partnership with SA Pathology. Pregnant women in South Australia can now access omega-3 testing through SA Pathology as part of routine antenatal care.
